ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
0.00%
Brent Oil
81.295
0.00%
Bitcoin
68,018.35
0.43%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Avidity Biosciences Inc (RNA)

  7. Avidity Biosciences Inc (RNA) Noticias

RNA Avidity Biosciences Inc

26.86
-0.20 (-0.74%)
31 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Avidity Biosciences Inc RNA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.20 -0.74% 26.86 23:00:07
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
27.11 26.35 27.7099 26.86 27.06
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/5/202415:05PRNUSAvidity Biosciences to Present Preliminary Data from Phase..
21/5/202415:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
16/5/202417:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202417:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/5/202408:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/5/202408:09EDGAR2Form 8-K - Current report
15/5/202408:00PRNUSAvidity Biosciences Announces Appointment of Simona..
09/5/202415:22EDGAR2Form S-3ASR - Automatic shelf registration statement of..
09/5/202415:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202415:07EDGAR2Form 8-K - Current report
09/5/202415:05PRNUSAvidity Biosciences Reports First Quarter 2024 Financial..
08/5/202415:05PRNUSAvidity Biosciences to Participate in Upcoming Investor..
08/5/202405:00PRNUSAvidity Biosciences Receives FDA Breakthrough Therapy..
07/5/202420:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/4/202415:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
27/3/202408:00PRNUSAvidity Biosciences to Participate in Upcoming Investor..
21/3/202415:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
08/3/202415:23EDGAR2Form 144 - Report of proposed sale of securities
05/3/202415:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202406:07EDGAR2Form 8-K - Current report
04/3/202406:00PRNUSAvidity Biosciences Announces Positive AOC 1001 Long-term..
01/3/202415:31EDGAR2Form 144 - Report of proposed sale of securities
29/2/202415:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202415:06EDGAR2Form 8-K - Current report
29/2/202411:00PRNUSAvidity Biosciences Honors Rare Disease Day®
29/2/202406:00PRNUSAvidity Biosciences Announces Oversubscribed $400 Million..
28/2/202416:32EDGAR2Form S-3ASR - Automatic shelf registration statement of..
28/2/202415:17EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202415:05PRNUSAvidity Biosciences Reports Fourth Quarter and Year-End 2023..
27/2/202408:00PRNUSAvidity Biosciences to Participate in Upcoming Investor..
21/2/202415:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
20/2/202408:00PRNUSAvidity Biosciences Receives FDA Rare Pediatric Disease..
15/2/202416:00PRNUSAvidity Biosciences to Present New AOC 1001 Long-term..
02/2/202411:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202414:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202414:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202414:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202415:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
05/1/202407:36EDGAR2Form 8-K - Current report
05/1/202407:30PRNUSAvidity Biosciences Announces 2024 Corporate Priorities and..
21/12/202315:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
14/12/202315:14EDGAR2Form 8-K - Current report
13/12/202307:30PRNUSAvidity Biosciences Reports Positive Data Demonstrating AOC..
29/11/202305:18IHMARKETNEWSAmazon Unveils Innovative Services, Okta Discloses Data..
28/11/202306:21DJNBristol Myers Squibb to Take Stake in Avidity Biosciences,..
28/11/202305:31EDGAR2Form 8-K - Current report
28/11/202305:30PRNUSAvidity Biosciences Announces Expansion of Cardiovascular..
21/11/202315:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
21/11/202308:00PRNUSAvidity Biosciences to Participate in Upcoming Investor..
08/11/202315:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Su Consulta Reciente

NASDAQ
RNA
Avidity Biosciences
LSE
FL83
New Dev Bk.26
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados